The pathway most frequently affected by mutations is the mitogen-activated protein kinase (MAPK) pathway, which includes the KRAS, NRAS, BRAF, EGR1, and FGFR3 genes, whose mutations have been detected in almost 50% of MM patients. Here, FGFR3 is linked to Miyoshi myopathy.